This talk will present an overview of the main findings in the initial "screening" phase of a multi-phased experimental process to explore methods of communicating risk regarding tamoxifen prophylaxis to women at high risk for breast cancer, with a particular emphasis on illustrating how Phase 1 data will be used to inform the design of the Phase 2 "refinement" study.

<a href="http://chcr.umich.edu/who_we_are/people/person.2005-04-13.0911105258/person_view">Peter Ubel</a> is an Associate Professor of Internal Medicine at the
University of Michigan School of Medicine, Director of the General
Medicine Health Services Research Fellowship at UM, and Staff Physician
at the Ann Arbor Veterans Affairs Medical Center.  He is also
Director of the Program of Improving Health Care Decisions, an
interdisciplinary research group jointly funded by the UM and the
Department of Veterans Affairs. He is a general internist who studies
issues related to decision psychology, economics, and bioethics. He is
currently principle investigator of three R01s from the NIH, all of
which involve extensive surveying of either patients or the general
public. He is a recipient of a Presidential Early Career Award for
Scientists and Engineers from President Clinton, and author of Pricing
Life: Why it's Time for Health Care Rationing (Bradford Books, a
division of MIT Press, 2000).<br><br><a href="http://chcr.umich.edu/what_we_do/projects/project.2004-07-02.4424203799/projects_page">Guide to Decide</a> is a project led by members of the Center for Behavioral and Decision Sciences in Medicine (CBDSM).  Our emphasis, in this Project, is to find unbiased ways of informing patients about important health care decisions.<br>